About eltrombopag olamine
Thrombopoietin receptor agonist
Used for
- Treats low platelet counts in chronic immune thrombocytopenia (ITP).
- Treats low platelets in hepatitis C patients receiving antiviral treatment.
- Treats severe aplastic anemia, including selected patients with persistent disease.
Usual adult dose
ITP: usually 50 mg once daily. Other conditions require condition-specific dosing and monitoring.
Usual dose in children
ITP: ages 1–5 years, usually 25 mg once daily; ages 6 years and older, usually 50 mg once daily. Other uses require specialist dosing.
Common side effects
- Nausea, diarrhea, or other digestive symptoms
- Headache
- Liver enzyme changes
- Blood clots
Important warnings
- Can cause serious liver injury; liver tests are needed.
- May raise platelet counts excessively and increase clot risk.
- Take separately from dairy, antacids, and mineral supplements.
- Do not stop or change treatment without medical supervision.
Pregnancy
Use only when clearly needed; human pregnancy information is limited.
Breastfeeding
Avoid breastfeeding during treatment; whether the medicine passes into human milk is unknown.
Interactions
- Calcium, iron, magnesium, aluminum, zinc, and dairy reduce absorption.
- May interact with rosuvastatin and other medicines processed by certain liver enzymes.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.